Loading clinical trials...
Loading clinical trials...
Personalized MECP2 Gene Therapy Using CRISPR/Cas9 Technology Coupled to AAV-mediated Delivery in 3D Cell Culture and KI Mice
Conditions
Interventions
Gene editing in vitro
Locations
1
Italy
University of Siena
Siena, Siena, Italy
Start Date
March 1, 2021
Primary Completion Date
November 1, 2025
Completion Date
March 1, 2026
Last Updated
August 20, 2025
NCT06139172
NCT06338267
NCT06856759
NCT06705816
NCT04463316
NCT06152237
Lead Sponsor
University of Siena
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions